AR095027A1 - VARIANTES DE a-AMILASA - Google Patents

VARIANTES DE a-AMILASA

Info

Publication number
AR095027A1
AR095027A1 ARP140100725A ARP140100725A AR095027A1 AR 095027 A1 AR095027 A1 AR 095027A1 AR P140100725 A ARP140100725 A AR P140100725A AR P140100725 A ARP140100725 A AR P140100725A AR 095027 A1 AR095027 A1 AR 095027A1
Authority
AR
Argentina
Prior art keywords
variant
polypeptide
amylase
seq
amino acid
Prior art date
Application number
ARP140100725A
Other languages
English (en)
Inventor
T Van Rij Evert
E Abbas Hanna
M De Jong Rene
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Publication of AR095027A1 publication Critical patent/AR095027A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A21BAKING; EDIBLE DOUGHS
    • A21DTREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
    • A21D8/00Methods for preparing or baking dough
    • A21D8/02Methods for preparing dough; Treating dough prior to baking
    • A21D8/04Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes
    • A21D8/042Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes with enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405Glucanases
    • C12N9/2408Glucanases acting on alpha -1,4-glucosidic bonds
    • C12N9/2411Amylases
    • C12N9/2414Alpha-amylase (3.2.1.1.)
    • C12N9/2417Alpha-amylase (3.2.1.1.) from microbiological source
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01001Alpha-amylase (3.2.1.1)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Un polipéptido variante que tiene actividad a-amilasa, en donde la variante tiene una secuencia de aminoácidos la cual, cuando se alinea con la a-amilasa que comprende la secuencia indicada en SEQ ID Nº 2, comprende al menos una sustitución de un residuo de aminoácido que se corresponde con cualquiera de los aminoácidos 4, 6, 13, 14, 15, 16, 20, 45, 47, 51, 54, 61, 68, 69, 70, 71, 72, 73, 74, 75, 77, 78, 80, 82, 87, 88, 94, 95, 100, 103, 104, 117, 124, 125, 126, 128, 130, 133, 134, 136, 143, 144, 146, 168, 174, 177, 178, 183, 186, 188, 189, 190, 194, 195, 199, 200, 201, 204, 207, 210, 214, 217, 219, 222, 225, 227, 233, 234, 235, 236, 240, 251, 252, 254, 258, 259, 260, 261, 262, 263, 264, 266, 267, 269, 271, 273, 281, 282, 283, 284, 286, 288, 299, 322, 323, 325, 327, 328, 331, 334, 350, 356, 358, 367, 370, 371, 374, 377, 378, 388, 391, 414, 421, 422, 445, 450, 467, 488, 505, 536, 548, 554, 583, 588, 603, 637, 648, 651, 652, 660, 676, 677 estando dichas posiciones definidas con referencia a SEQ ID Nº 2 y en donde la variante tiene una o más propiedades alteradas en comparación a un polipéptido de referencia que tiene actividad a-amilasa. Dicho polipéptido variante puede usarse en la preparación de un producto horneado.
ARP140100725A 2013-03-01 2014-03-06 VARIANTES DE a-AMILASA AR095027A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP13157398 2013-03-01

Publications (1)

Publication Number Publication Date
AR095027A1 true AR095027A1 (es) 2015-09-16

Family

ID=47750572

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP140100725A AR095027A1 (es) 2013-03-01 2014-03-06 VARIANTES DE a-AMILASA

Country Status (2)

Country Link
US (2) US9301533B2 (es)
AR (1) AR095027A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2020010422A (es) * 2018-04-05 2020-10-28 Dsm Ip Assets Bv Alfa-amilasa maltogenica variante.
EP4056635A1 (en) 2021-03-12 2022-09-14 Premo, Sa A thermal conductive composition, a thermal conductive potting for sealing a magnetic power assembly, a power transformer assembly and an electrical vehicle
WO2023187753A1 (en) * 2022-04-01 2023-10-05 Danstar Ferment Ag N-terminus engineering of intracellular polypeptides expressed in recombinant eukaryotic host cells

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK135983D0 (da) 1983-03-25 1983-03-25 Novo Industri As Maltogen amylaseenzymprodukt og fremgangsmade til dets fremstilling og anvendelse
USRE38507E1 (en) 1989-09-27 2004-04-27 Novozymes A/S Antistaling process and agent
WO1999043794A1 (en) 1998-02-27 1999-09-02 Novo Nordisk A/S Maltogenic alpha-amylase variants
AU761751B2 (en) 1998-02-27 2003-06-12 Novozymes A/S Amylolytic enzyme variants
GB0305685D0 (en) 2003-03-12 2003-04-16 Danisco Enzyme
WO2006012902A2 (en) 2004-08-02 2006-02-09 Novozymes A/S Creation of diversity in polypeptides
EP1797179A1 (en) 2004-08-02 2007-06-20 Novozymes A/S Maltogenic alpha-amylase variants
DK1794291T3 (da) 2004-09-24 2013-03-04 Novozymes As Fremgangsmåde til fremstilling af et dejbaseret produkt
DK2164958T3 (en) 2007-06-07 2014-11-24 Novozymes As A process for preparing a dough-based product
CN102639687A (zh) 2009-11-13 2012-08-15 诺维信公司 酿造方法
EP2620496B1 (en) * 2012-01-30 2015-06-03 DSM IP Assets B.V. Alpha-amylase

Also Published As

Publication number Publication date
US9301533B2 (en) 2016-04-05
US9808018B2 (en) 2017-11-07
US20150376588A1 (en) 2015-12-31
US20140248397A1 (en) 2014-09-04

Similar Documents

Publication Publication Date Title
EP4234689A3 (en) Split inteins with exceptional splicing activity
CL2017001070A1 (es) Variantes de interferon a2b
PH12016501671A1 (en) Novel polysaccharide and uses thereof
TN2017000085A1 (en) Polypeptide having a polyester degrading activity and uses thereof
MX2017009538A (es) Antigenos de citomegalovirus y su uso.
WO2015120287A3 (en) Compositions and methods of use thereof for making polypeptides with many instances of nonstandard amino acids
EP3119424A4 (en) Immunogenic glycopeptides, composition comprising the glycopeptides and use thereof
JO3765B1 (ar) لقاحات علاجية لفيروس الورم الحليمي البشري 18 (18hpv)
ES2721309T3 (es) Composición para preparar tagatosa y método para preparar tagatosa a partir de fructosa
NZ701125A (en) Improved chymosine enzyme variants
PH12017501084A1 (en) Insulin glargine/lixisenatide fixed ratio formulation
BR112015020692A2 (pt) variantes de alfa-amilase
PH12017500450A1 (en) Flavivirus virus like particle
AR102410A1 (es) Polipéptidos que tienen actividad xilanasa con una tasa de conversión alta de polisacáridos que contienen xilosa
CO2017011964A2 (es) Un metodo para producir hcg recombinante
WO2015185758A3 (en) Preparation comprising factor viii and von willebrand factor peptides
EP4043558A3 (en) Kaurenoic acid hydroxylases
CA2899089C (en) Factor ix polypeptide formulations
AR095027A1 (es) VARIANTES DE a-AMILASA
CL2019000429A1 (es) Conjugado de minoxidil y peptidos.
WO2015000053A8 (en) Enzyme formulation for use as food supplement
EP3538648A4 (en) RECOMBINANT VIRUS, COMPOSITION COMPRISING SAME AND CORRESPONDING USES
MX2018013556A (es) Polipeptidos variantes con rendimiento mejorado y uso de los mismos.
PH12017550079A1 (en) Composition for improving memory, learning ability and cognition
AR101710A1 (es) VARIANTES DE a-AMILASA

Legal Events

Date Code Title Description
FB Suspension of granting procedure